Multiomics – News and Features

Company’s high-quality human genome sequencing technology is helping to further cancer, metabolic and neurologic disease research.

caCORRECT and omniBioMarker are being made available to cancer researchers to remove artifacts and identify and validate biomarkers from microarray data.

Phase II of the HHMI-NIBIB interfaces initiative for interdisciplinary graduate research training.

The SBIR grant will be used to develop a database and systems biology tool-set specifically designed for pharmacogenomic research.

Cellumen to provide its CellCiphr analysis in the second phase of the U.S. Environmental Protection Agency’s ToxCast™ program.

UK bioscience has received a major boost following the announcement of 16 new fellowships by the Biotechnology and Biological Sciences Research Council (BBSRC) including the first ever Diamond Fellowship, so named because the post will be based at the new Research Complex at Harwell, adjacent to the Diamond Light Source in Oxfordshire - the UK national synchrotron facility.

The symposium addressing functional characterization of biomolecular stability and interactions.

GENEART to produce required genes and gene variants within the BMBF Joined Project IG Mutanom over the next two years.

Lilly licenses a customized version of Physiomics’ ModelPlayer for in silico simulations of unspecified anticancer drugs.

Michigan Center for Translational Pathology uses Genomatix technology for data analysis of their in-house deep sequencing systems.